Completed PHASE4 INTERVENTIONAL 2-arm NCT04480281

Intravenous Lidocaine in Open Lung Resection Surgery

Intravenous Lidocaine Reduces Pain Scores and Opioid Consumption in Open Lung Resection Surgery: A Prospective Randomized Double-Blind Controlled Trial

Sponsor: Saint-Joseph University

Conditions Lidocaine Pain, Postoperative

Interventions Lidocaine Iv Normal Saline

Updated 4 times since 2020 Last updated: Jul 20, 2020 Started: Jan 10, 2020 Primary completion: May 15, 2020 Completion: May 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Lidocaine and Pain, Postoperative and is currently completed. Saint-Joseph University leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2020 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Saint-Joseph University

Data source: Saint-Joseph University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beirut, Lebanon